ARCHIVES

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

This article is from The Cancer Letter archive.

Vol. 33 No. 6 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007

Public Health Service: Blumenthal Declines White House Job

November 14, 1997

Researchers Identify Mutation Linked to Inherited Risk of ALL

September 27, 2013

NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”

May 7, 1993

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

NCI Supercomputer Operations To Start In April

November 15, 1985